HARARE – United Kingdom-based GlaxoSmithKline plc (GSK), a leading global research-based pharmaceutical and healthcare company, has stopped operations in Zimbabwe due to the country’s high political risk profile. Zimbabwe is regarded by foreign investors as a high political and credit risk country due to the fragile political environment and the country’s failure to service its…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions